Search

everythinglearnresearchcommunity

for

Search:↓

Researchers created a new mouse model for studying Citrullinemia Type I and similar conditions, showing symptoms and treatment responses like those in humans.

Fat stem cells from diabetic mice can still help heal wounds.

Citrullinated proteins from Porphyromonas gingivalis may contribute to rheumatoid arthritis.

Bacteroides fragilis and Microbacterium sp. T32 may be linked to autoimmune activity in Hashimoto's thyroiditis and alopecia areata.

Cell detachment, not autoantibody binding, causes major changes in pemphigus.

Tofacitinib helps improve skin conditions in people with Down syndrome, especially alopecia areata.

People with atopic dermatitis have more CD4+ T cells that respond to a certain bacterial lipid, which may play a role in the skin condition's inflammation.

Blocking IL-12/IL-23 does not help with hair loss in alopecia areata for mice or humans.

Low-dose intralesional corticosteroid treatment led to rapid hair regrowth in localized alopecia areata.

A specific DNA pattern in Malassezia restricta may be linked to hair loss in men.

A new mix of anthralin and calcipotriene might help treat severe hair loss.

Non-invasive imaging helped diagnose a woman's severe hormone imbalance and diabetes, and medication successfully treated her condition.

Upadacitinib effectively treats pyoderma gangrenosum.

A mouse model for studying scleroderma in chronic graft-versus-host disease was successfully created.

Some medications can improve skin conditions, while lifestyle factors like smoking and drinking may worsen them; treatments like monoclonal antibodies and imiquimod cream show promise for certain skin diseases.

Intralesional triamcinolone injections can effectively stop frontal fibrosing alopecia with minimal side effects.

Hepatitis B virus exposure may be linked to increased risk of alopecia areata.

GLI1 might protect against the start of skin cancer and is not linked to cancer severity.

Managing multiple autoimmune diseases in one patient is extremely challenging.

Distinguishing drug-induced lupus from systemic lupus is challenging and requires careful monitoring.

Late-onset alopecia areata in Taiwanese patients is more common in women, usually starts at age 57, often involves less than 10% hair loss, and may have a minimal link to thyroid issues.

Adalimumab can cause complete hair loss in rare cases.

Cow colostrum and milk can effectively produce anti-hair keratin antibodies.

Tph cells are linked to the severity of systemic lupus erythematosus.

Cutaneous lupus patients have higher levels of certain immune cells in their blood and skin.

Uncombable hair syndrome causes frizzy hair and can affect the nervous system, eyes, and ears, often co-occurring with other hair, skin, nail, and teeth conditions, and is linked to three specific gene mutations.

Targeting CD200 could be a new treatment for rheumatoid arthritis.

The new aptamer TAGX-0003 shows promise as an effective treatment for hair loss disorder alopecia areata.